Received May 8, 2026
Reports are unverified and do not show that a vaccine caused an event. Full disclaimer
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | 1 | Z011334 | IM / LA |
Patient noted to have rash/reaction at the right upper arm following vaccination, characterized by erythema, swelling and significant tenderness at the injection site. Patient demonstrates wincing with mild palpitation/touch due to pain. Swelling radiates proximally toward the right shoulder. Area noted to be red and inflamed. Patient denies drainage. No fever noted at time of visit; however, patient reports taking tylenol every 6 hours for symptom management. Patient advised to go to Emergency room for evaluation and treatment. Patient agreed.
Iron deficiency anemia,
BMI 50.0-59.9, adult (HCC) ? Former smoker ? Iron deficiency anemia ? Encounter for cholecystectomy ? Vertigo ? H/O gastric sleeve ? Severe obesity (HHS-HCC) ? Uses (withheld) as primary spoken language ? Abdominal pannus ? Asthma (HHS-HCC) ? Edema of lower extremity ? Knee pain
tirzepatide, weight loss, (ZEPBOUND) 7.5 mg/0.5 mL pnij Inject 7.5 mg under the skin once a week. ? ergocalciferol (VITAMIN D-2) 1,250 mcg (50,000 unit) capsule Take 50,000 Units by mouth once a week. ? meloxicam (MOBIC) 7.5 mg tablet Take
NKA
none
Covid, Moderna 033K21-2A, 3/16/22 and Moderna 013H21B 2/16/22